Melatonin and antitoxin K mitigate the expression levels of TNF-α, IL-1β, and IL-8 in SFs, thereby reducing cartilage degradation and improving RA symptoms [83,139]. This evidence concerns the gene CXCL8 and rheumatoid arthritis.